Stay updated on Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page history now shows Revision: v3.6.5 instead of v3.6.4, indicating a small update to the study record history display/backend. The change does not modify study data or visible content beyond the version label.
    Difference
    0.1%
    Check dated 2026-08-10T13:23:24.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page shows a new site revision: v3.6.4, replacing v3.6.3. This indicates a small update to the site's interface/backend.
    Difference
    0.1%
    Check dated 2026-07-27T06:26:04.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    A new Study Status row has been added to the history, and a new version (51) was recorded on 2026-07-14. An older history entry dated 2026-04-22 was removed.
    Difference
    0.2%
    Check dated 2026-07-20T01:15:56.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.6.2 to v3.6.3, signifying a newer version of the page in the study history and likely minor maintenance updates.
    Difference
    0.1%
    Check dated 2026-07-05T14:29:25.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a newer version of the record history page.
    Difference
    0.1%
    Check dated 2026-06-28T08:22:14.000Z thumbnail image
  9. Check
    76 days ago
    Change Detected
    Summary
    The history now shows the study is no longer looking for participants, indicating enrollment has ceased. The entries also add a new revision label v3.6.0 as the current version, replacing the previous v3.5.5 reference.
    Difference
    0.2%
    Check dated 2026-06-14T05:04:32.000Z thumbnail image

Stay in the know with updates to Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page.